Versions Compared

Old Version 12

changes.mady.by.user April Seaward

Saved on

compared with

New Version 13

changes.mady.by.user April Seaward

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Clin Pharm.jpg
ASCPT.png Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone
Created by Intishar Kazi, Meghan Chenoweth, Didier Jutras-Aswad, Keith Ahamad, M. Eugenia Socias, Bernard Le Foll, Rachel Tyndale
Methadone and buprenorphine/naloxone are opioid agonist therapies for opioid use disorder treatment. Genetic factors contribute to individual differences in opioid response…
https://doi.org/10.1186/s12906-023-04312-1
https://doi.org/10.1001/jamanetworkopen.2023.52233
https://doi.org/10.1016/j.brs.2024.01.008
add.v119.2.cover.jpg
Wiley.icoImage Removed Wiley.jpgImage Added Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials
Created by Heidar Sharafi, Hamzah Bakouni, Christina McAnulty, Sarah Drouin, Stephanie Coronado-Montoya, Arash Bahremand, Paxton Bach, Nadine Ezard, Bernard Le Foll…
There is currently no standard of care for pharmacological treatment of amphetamine-type stimulant (ATS) use disorder (ATSUD). This systematic review with meta-analysis (PROSPERO CRD42022354492) aimed to pool results from randomized placebo-controlled trials (RCTs) to evaluate efficacy and safety of prescription psychostimulants (PPs) for ATSUD…
https://www.cmaj.ca/content/196/6/E187

...